1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNIA Small Business Interest Areas (SBIR/STTR) is sponsored by National Institute on Aging (NIA). Seeks proposals to develop and validate technologies that enhance the health and well-being of older adults, including assistive devices, robotics, sensors, and digital health products.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small businesses conducting research and development to develop interventions that support healthy aging or address aging-related diseases and conditions. Confirm the full requirements in the official notice before applying.
The current listing shows up to $500,000 (Phase I); Up to $2.5 Million (Phase II) for general projects; up to $700,000 (Phase I) and $3 Million (Phase II) for Alzheimer's and Related Dementias projects. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for NIA Small Business Interest Areas (SBIR/STTR) are due January 5, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NIA Small Business Interest Areas (SBIR/STTR) is funded by National Institute on Aging (NIA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article